Company Profile

Intermediate (n-1) formulations, enable pharmaceutical companies to achieve the goal of local manufacturing of “oral solid dosage” & “Dry syrup” forms with following advantages • Reduced time to commercialization • Reduced capital expenditure • Reduced requirement for technical expertise • Quicker access to new products • Access to regulatory dossier documentation & stability studies